Sign In
/
Register
Sign In
Register
Close
Close
Home
Pensions
Pensions Home
Personal Pension
Sipp
Auto-enrolment
State Pension
Retirement Income
Ssas
Investments
Investments Home
Responsible Money
Equities
Vantage Point
ESG Investing
Fixed Income
Investment Trusts
Multi-asset
Platforms
Model Portfolios
Talking Point
Mortgages
Mortgages Home
Residential
Buy-to-let
Commercial
Protection
Protection Home
Life Insurance
Critical Illness
Income Protection
Business Protection
Regulation
Regulation Home
Financial Conduct Authority
Financial Ombudsman Service
FSCS
Tax
Tax Home
Inheritance Tax
Capital Gains Tax
Avoidance
Tax Efficient Investments
National Insurance
HMRC
Your Industry
Your Industry Home
FT Wealth Management
Trade Bodies
Paraplanning
Consumer duty
Mergers and Acquisitions
Diversity and Inclusion
Opinion
Opinion Home
Liz Field
Simoney Kyriakou
Jeff Prestridge
Ken Davy
Stephanie Hawthorne
Ben Goss
Darren Cooke
Ask the Expert
CPD
Asset Allocator
Asset Allocator Home
Equities
Fixed Income
Alternatives
Income
Growth
Value
Active
Passive
Podcast
Home
Pensions
Personal Pension
Sipp
Auto-enrolment
State Pension
Retirement Income
Ssas
Investments
Responsible Money
Equities
Vantage Point
ESG Investing
Fixed Income
Investment Trusts
Multi-asset
Platforms
Model Portfolios
Talking Point
Mortgages
Residential
Buy-to-let
Commercial
Protection
Life Insurance
Critical Illness
Income Protection
Business Protection
Regulation
Financial Conduct Authority
Financial Ombudsman Service
FSCS
Tax
Inheritance Tax
Capital Gains Tax
Avoidance
Tax Efficient Investments
National Insurance
HMRC
Your Industry
FT Wealth Management
Trade Bodies
Paraplanning
Consumer duty
Mergers and Acquisitions
Diversity and Inclusion
Opinion
Liz Field
Simoney Kyriakou
Jeff Prestridge
Ken Davy
Stephanie Hawthorne
Ben Goss
Darren Cooke
Ask the Expert
CPD
Asset Allocator
Equities
Fixed Income
Alternatives
Income
Growth
Value
Active
Passive
Podcast
Search
Close
Global
Feb 17 2017
Guinness duo wary of US mid caps
Search supported by
Matthew Page says Swiss pharmaceutical giant Roche was added to the portfolio in the final quarter of 2016
By
Matthew Jeynes
Related articles
Royal London closes £285mn global equity fund
What are convertible bonds and when to use them?
How to help clients align visions and values
Most Read
Defined Benefit
Apr 25 2024
DB complaints are increasing: what should advisers do?
Quilter
Apr 24 2024
Quilter kicks off skilled person review into ongoing advice
Paraplanning
Apr 25 2024
'I didn't want an advisory role, I'm not a massive people person'
Related articles
Global
Feb 5 2024
Royal London closes £285mn global equity fund
Investments
Apr 9 2024
What are convertible bonds and when to use them?
Work and wellbeing
Apr 5 2024
How to help clients align visions and values
Long Read
Mar 28 2024
Why has a £50bn US hedge fund become Scottish Mortgage’s biggest shareholder?
Long Read
Mar 27 2024
Investors must not let election buzz mess with their long-term strategy
Related Topics
Equity
US
Equity Income
For unlimited access to FTAdviser content...
Register now for free
Read the latest news and views from the world of financial advice
Never miss a story - sign up to our email alerts
Bank CPD while you read
Register
Have an account?
Sign In